# OnCo record rejuv-access-survivorship-care-us (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/rejuv-access-survivorship-care-us/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "rejuv-access-survivorship-care-us" ;
  schema:name "After treatment in the United States: the survivorship care plan, and what the trial found"@en ;
  schema:description "The United States answer to life after treatment was a written survivorship care plan, made an accreditation requirement for cancer centres. The randomised trial of it found no benefit on any patient-reported outcome, and the requirement was later replaced with a broader survivorship programme standard."@en ;
  schema:url <https://onco.cc/technologies/rejuv-access-survivorship-care-us/> ;
  schema:dateModified "2026-10-02"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Cancer_survivor> ;
  schema:citation <https://doi.org/10.1200/JCO.2011.36.8373>, <https://www.cancer.gov/about-cancer/coping/survivorship/follow-up-care>, <https://doi.org/10.1093/jnci/djz089>, <https://doi.org/10.1007/s10900-017-0365-0>, <https://doi.org/10.1007/s00520-024-08796-6>, <https://www.cms.gov/priorities/innovation/innovation-models/enhancing-oncology-model> ;
  onco:status "established" ;
  onco:tag "rejuvenation", "survivorship", "evidence:no-benefit", "access", "us" ;
  onco:related <https://onco.cc/technologies/rejuv-access-survivorship-care-uk/>, <https://onco.cc/technologies/rejuv-paed-transition-to-adult-care/> ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/rejuvenation/>, <https://onco.cc/fronts/supportive-care/> ;
  onco:technologies <https://onco.cc/technologies/survivorship-care-plan/>, <https://onco.cc/technologies/rejuv-measure-epro-implementation/>, <https://onco.cc/technologies/rejuv-access-who-misses-out/>, <https://onco.cc/technologies/rejuv-access-what-it-costs-us/>, <https://onco.cc/technologies/financial-navigation/>, <https://onco.cc/technologies/psycho-oncology/> ;
  onco:institutions <https://onco.cc/institutions/nci/> ;
  onco:terms <https://onco.cc/terms/late-effects/>, <https://onco.cc/terms/quality-of-life/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-survivorship/>, <https://onco.cc/bottlenecks/b-care-fragmentation/>, <https://onco.cc/bottlenecks/b-incentive-misalignment/> .